US Patent Issued to Alphelix Biotech on July 15 for "Antibodies specifically binding to CD147 and uses thereof" (Chinese Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,691, issued on July 15, was assigned to Alphelix Biotech Co. Ltd. (Guangdong, China).

"Antibodies specifically binding to CD147 and uses thereof" was invented by Xiangai Zhou (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to antibodies specifically binding to CD147 or antigen-binding fragment thereof, and a method of treating a disease or condition in a subject in need thereof, comprising administering to the subject an anti-CD147 antibody or antigen-binding fragment, or a polynucleotide encoding the anti-CD147 antibody or antigen-binding fragment, or a pharmaceutical composition comprising the anti-C...